Skip to main content
# Title Department Research Year
71 Naturally occurring phenylethanoids and phenylpropanoids: antimalarial potential Department of Pharmacognosy 2023
72 Novel Drugs Obtained via Biotransformation—In Memory of the Late Scientists Frieder Schauer and Peter Grunwald 2023
73 Thiadiazine-2-thione derivatives as new cell- cycle inhibitors Department of Medicinal Chemistry 2023
74 Monitoring antiviral active metabolite (N-hydroxycytidine) levels in plasma in presence of carboxylesterase-2 inhibitor verapamil using copper tetracyanoquinodimethane enhanced sensor Department of Pharmaceutical Analytical Chemistry 2023
75 Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation Department of Pharmaceutical Organic Chemistry 2023
76 LIPID NANOPARTICLES TECHNOLOGY IN VACCINES; SHAPING THE FUTURE OF PROPHYLACTIC MEDICINE Department of Industrial Pharmacy 2023
77 New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents Department of Pharmaceutical Organic Chemistry 2023
78 Phytochemical Investigation, In silico/In vivo Analgesic, and Anti-inflammatory Assessment of the Egyptian Cassia occidentalis L. Department of Pharmacognosy 2023
79 Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain Department of Pharmaceutics 2023
80 Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive Department of Pharmacology 2023